Showing results (131-140 of 136) with videos related to
Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 136 results.
Emerging Infectious Diseases|March 2, 2025
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with DiabetesEkaterina V Kurbatova, William C Whitworth, Lakshmi Praveena Peddareddy, et al.Tuberculosis Research and Treatment|April 17, 2014
Tuberculin Skin Tests versus Interferon-Gamma Release Assays in Tuberculosis Screening among Immigrant Visa ApplicantsStella O Chuke, Nguyen Thi Ngoc Yen, Kayla F Laserson, et al.Contemporary Clinical Trials|March 13, 2021
Central monitoring in a randomized, open-label, controlled phase 3 clinical trial for a treatment-shortening regimen for pulmonary tuberculosisKia E Bryant, Yan Yuan, Melissa Engle, et al.Emerging Infectious Diseases|January 6, 2026
Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016-2020Ekaterina V Kurbatova, William C Whitworth, Kia E Bryant, et al.American Journal of Respiratory and Critical Care Medicine|July 16, 2024
Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized Controlled Clinical TrialAva Y Xu, Gustavo E Velásquez, Nan Zhang, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2021
Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose RifapentineAnthony T Podany, Michelle Pham, Erin Sizemore, et al.Pageof 14